Skip to main content
  • Novel Sirolimus-Coated Balloon Noninferior in De Novo Coronary Lesions vs. Best-in-Class Paclitaxel-Coated Balloon: Malaysian Trial

    The novel SeQuent sirolimus coated balloon (SCB) proved to be non-inferior at treating new coronary lesions versus the best-in-class paclitaxel-coated balloon (PCB), SeQuent Please Neo, in a new Malaysian trial.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details